Abbott Reaches Deal To Reopen Baby Formula Plant

CNBC reports:

Abbott has reached an agreement with the Food and Drug Administration to reopen its manufacturing plant in Michigan to help ease a nationwide shortage of baby formula, the company announced Monday. Abbott said it can restart the Michigan plant within two weeks subject to FDA approval.

However, it would take six to eight weeks from the start of production for formula to arrive on store shelves, according to the company. The agreement between Abbott and the FDA, called a consent decree, is subject to court approval.

The supply shortage was triggered in part by the closure of Abbott Nutrition’s manufacturing plant in Michigan after four infants who consumed formula from the facility fell ill from bacterial infections, two of whom subsequently died.

Read the full article.

Abbott Reaches Agreement With FDA to Reopen Baby Formula Plant to Ease Nationwide Shortage https://t.co/Ms9JBqc5iB

— NBC4 Washington (@nbcwashington) May 16, 2022